| Followers | 843 |
| Posts | 122806 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Friday, February 16, 2018 5:46:22 PM
[Miscellaneous updates.]
Proprietary autoimmune program
• 1H18: Start phase-1 trial of M230, which is partnered with CSL (#msg-127656306).
• 2018: Report full dataset from M281 phase-1 trial at an unspecified medical conference. (Top-line data were reported in Jan 2018: #msg-137491062.)
• 2018 Start phase-1 trial of M254, a hyper-sialylated IVIG.
FoB program
• Timing unknown: M923 (Humira FoB) partnership or divestiture.
• 1H18: Start phase-3 trial for M710 (Eylea FoB).
• 2018: Report reason for inability of M834 (Orencia FoB) to meet its phase-1 pharmacokinetic endpoint; start phase-1 do-over, if necessary.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
